▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4188 by analyst upside · 2026-09-27
TEM
Tempus AI, Inc.
Healthcare · Market Cap $15B · P/E 0x
ANALYST PRICE TARGET
-19.4%
implied upside to consensus target
Current Price $85.01
Consensus Target $68.56
Bull Target $100.0
Bear Target $35.0
Analysts Covering 18
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
7
Hold
8
Sell
1
52-Week Low $40.77
52-Week High $104.32
YTD Return +36.3%
FUNDAMENTALS
Market Cap $15B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.44
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $1.4B
Profit Margin -17.8%
52-WEEK RANGE
52-Week Low $40.77
52-Week High $104.32
Current Price $85.01
Bear Target $35.0
Bull Target $100.0
● Now $85.01 ● Target $68.56
TRADING DATA
Avg Volume 6.5M
YTD Return +36.3%
Analyst Count 18
Consensus Buy
Upside to Target -19.4%
Last Updated 2026-09-27

ANALYST SUMMARY

Tempus AI, Inc. (TEM) is currently trading at $85.01 with a Wall Street consensus price target of $68.56, which is 19.4% below the current price over the next 12 months. 18 analysts currently cover TEM, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $100.0, while the most cautious has a target of $35.0.

TEM operates in the Healthcare sector with a market capitalisation of $15B. The stock is up 36.3% year-to-date and is currently trading near the upper end of its 52-week range of $40.77 – $104.32.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TEM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Goldman Sachs ● Initiated
Neutral 2026-09-21 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-09-11 31% win rate (48 calls)
UBS ● Initiated
Neutral 2026-09-09 33% win rate (6 calls)
Rothschild & Co ● Initiated
Neutral 2026-09-08 Building track record
Roth Capital ● Initiated
Neutral 2026-09-08 Building track record
Cantor Fitzgerald ● Initiated
Overweight 2026-09-02 40% win rate (10 calls)
Piper Sandler ↑ Upgrade
Neutral → Overweight 2026-09-01 14% win rate (7 calls)
Freedom Capital Markets - Reiterated
Hold → Hold 2026-08-31 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
44
out of 100
Coverage depth
22/30
Consensus clarity
15/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →